Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation study

Seth E. Karol(St. Jude Children's Research Hospital), Thomas Alexander(University of North Carolina at Chapel Hill), Amit Budhraja(St. Jude Children's Research Hospital), Stanley Pounds(St. Jude Children's Research Hospital), Kristin Canavera(St. Jude Children's Research Hospital), Lei Wang(St. Jude Children's Research Hospital), Joshua Wolf(St. Jude Children's Research Hospital), Jeffery M. Klco(St. Jude Children's Research Hospital), Paul E. Mead(St. Jude Children's Research Hospital), Soumyasri Das Gupta(St. Jude Children's Research Hospital), Su Y. Kim(AbbVie (United States)), Ahmed Hamed Salem(Ain Shams University), Tammy L. Palenski(AbbVie (United States)), Norman J. Lacayo(Palo Alto University), Ching‐Hon Pui(St. Jude Children's Research Hospital), Joseph T. Opferman(St. Jude Children's Research Hospital), Jeffrey E. Rubnitz(St. Jude Children's Research Hospital)
The Lancet Oncology
March 11, 2020
Cited by 162Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis